NASDAQ:QURE

Uniqure N.v Stock Insider Trading

etoro logo Buy QURE
*Your capital is at risk
$29.88
+3.12 (+11.66%)
At Close: Jun 03, 2026

uniQure N.V Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -83.37. In total, the insiders bought 1.97M and sold 786.77K QURE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-83.37
Buy 1.97M shares
Sell 786.77K shares
47% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 04, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -83.37.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 08, 2026
Buy
Ordinary Shares
M-Exempt
Abi-saab Walid
Chief Medical Officer
Officer 25 000
Value: $139.8K
May 08, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 25 000
Value: $627.5K
May 08, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 20 000
Value: $500.0K
May 08, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Abi-saab Walid
Chief Medical Officer
Officer 25 000
Value: $139.8K
Mar 04, 2026
Buy
Ordinary Shares
A-Award
O'keefe Kylie
Chief Customer & Strat Officer
Officer 19 800
Value: $179.0K
Mar 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
O'keefe Kylie
Chief Customer & Strat Officer
Officer 31 900
Value: $288.4K
Mar 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Klemt Christian
Chief Financial Officer
C-Suite Officer 63 900
Value: $577.7K
Mar 04, 2026
Sell
Ordinary Shares
S-Sale
Klemt Christian
Chief Financial Officer
C-Suite Officer 12 000
Value: $108.7K
Mar 04, 2026
Buy
Ordinary Shares
A-Award
Klemt Christian
Chief Financial Officer
C-Suite Officer 39 600
Value: $358.0K
Mar 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Potts Jeannette
Chief Legal Officer
Officer 57 200
Value: $517.1K
Mar 04, 2026
Sell
Ordinary Shares
S-Sale
Potts Jeannette
Chief Legal Officer
Officer 3 412
Value: $30.9K
Mar 04, 2026
Buy
Ordinary Shares
A-Award
Potts Jeannette
Chief Legal Officer
Officer 35 400
Value: $320.0K
Mar 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Abi-saab Walid
Chief Medical Officer
Officer 67 200
Value: $607.5K
Mar 04, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 808
Value: $7K
Mar 04, 2026
Buy
Ordinary Shares
A-Award
Abi-saab Walid
Chief Medical Officer
Officer 41 700
Value: $377.0K
Mar 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Kapusta Matthew C
CEO, Managing Director
CEO / President 113 800
Value: $1.03M
Mar 04, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 14 581
Value: $132.1K
Mar 04, 2026
Buy
Ordinary Shares
A-Award
Kapusta Matthew C
CEO, Managing Director
CEO / President 70 600
Value: $638.2K
Mar 02, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 1 660
Value: $16.5K
Mar 02, 2026
Sell
Ordinary Shares
S-Sale
Potts Jeannette
Chief Legal Officer
Officer 8 578
Value: $85.4K
Mar 02, 2026
Sell
Ordinary Shares
S-Sale
Klemt Christian
Chief Financial Officer
C-Suite Officer 12 532
Value: $124.7K
Mar 02, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 34 437
Value: $342.6K
Feb 25, 2026
Buy
Ordinary Shares
O'keefe Kylie
Chief Customer & Strat Officer
Officer 0
Value: $0
Feb 25, 2026
Buy
Stock Option (Right to Buy)
O'keefe Kylie
Chief Customer & Strat Officer
Officer 180 000
Value: $2.92M
Feb 25, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 12 378
Value: $295.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNIQURE N.V.
uniQure N.V
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE